Eventide Asset Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,394,336
| Closed | -$2.37M | – | 256 |
|
|
2025
Q1 | $2.37M | Hold |
1,394,336
| – | – | 0.05% | 159 |
|
|
2024
Q4 | $4.45M | Hold |
1,394,336
| – | – | 0.08% | 156 |
|
|
2024
Q3 | $3.13M | Hold |
1,394,336
| – | – | 0.05% | 148 |
|
|
2024
Q2 | $3.13M | Hold |
1,394,336
| – | – | 0.05% | 141 |
|
|
2024
Q1 | $3.13M | Hold |
1,394,336
| – | – | 0.05% | 141 |
|
|
2023
Q4 | $3.25M | Buy |
+1,394,336
| New | +$3.25M | 0.05% | 137 |
|
|
2018
Q2 | – | Sell |
-347
| Closed | -$940K | – | 151 |
|
|
2018
Q1 | $940K | Buy |
+347
| New | +$940K | 0.04% | 134 |
|